Page last updated: 2024-12-05

potassium cyanide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID9032
CHEMBL ID2228308
CHEBI ID33191
MeSH IDM0017377

Synonyms (60)

Synonym
cyanide of potassium
zyankali
kaliumcyanid
kaliumzyanid
151-50-8
CHEBI:33191 ,
kcn
rcra waste number p098
m-44 capsules (potassium cyanide)
brn 4652394
rcra waste no. p098
caswell no. 688a
un1680
einecs 205-792-3
potassium cyanide k(cn)
cyanure de potassium [french]
hsdb 1245
ai3-28749
epa pesticide chemical code 599600
hydrocyanic acid, potassium salt
kalium cyanid [german]
potassium cyanide ,
potassium cyanide (k(cn))
cyanide, potassium
kalium cyanid
potassium cyanide, bioultra, >=98.0% (at)
AKOS009159058
cyanure de potassium
unii-mqd255m2zo
ec 205-792-3
mqd255m2zo ,
potassium cyanide [un1680] [poison]
P1613
BP-30182
CHEMBL2228308
kali cyanatum [hpus]
kali cyanatum
potassium cyanide [mi]
potassium cyanide [hsdb]
NNFCIKHAZHQZJG-UHFFFAOYSA-N
potassiumcyanide
potasium cyanide
cyanopotassium
YUZRZFQHUCKACF-UHFFFAOYSA-N
DTXSID0024268 ,
potassium cyanide, acs reagent, >=96.0%
potassium cyanide, saj first grade, >=95.0%
potassium cyanide, technical, >=96%
potassium cyanide, puriss. p.a., acs reagent, reag. ph. eur., >=97.0%
potassium cyanide, jis special grade, >=98.0%
bdbm50486225
potassium cyanide, p.a., acs reagent, 97.0%
potassium cyanide acs grade
potassium cyanide, granular
Q192470
potassium;cyanide
potassium cyanide(kcn)
dtxcid804268
caswell no 688a
potassium cyanide, (solid)

Research Excerpts

Overview

Potassium cyanide (KCN) is an inhibitor of cytochrome C oxidase causing rapid death due to hypoxia.

ExcerptReferenceRelevance
"Potassium cyanide (KCN) is an inhibitor of cytochrome C oxidase causing rapid death due to hypoxia. "( Characterization of a Mouse Model of Oral Potassium Cyanide Intoxication.
Gibbs, ST; Hong, P; Kobs, CL; Matthews, CM; Patton, KM; Sabourin, CL; Sabourin, PJ; Wakayama, EJ, 2016
)
2.14

Actions

ExcerptReferenceRelevance
"Potassium cyanide could inhibit denitrification; hydrazine and hydroxyamine could inhibit nitrification."( [Isolation of bacteria which could perform nitrification and denitrification simultaneously by gene probe].
Tsay, SS; Yu, PJ, 1997
)
1.02

Treatment

Pretreatment with potassium cyanide (KCN) greatly increased CN-resistant R and reduced reactive oxygen species (ROS) formation. Application of salicylhydroxamic acid (SHAM, an AOX inhibitor) blocked the AOX activity and enhanced the production of ROS in the plants.

ExcerptReferenceRelevance
"Potassium cyanide (KCN) treatment and serum starvation of cells yielded similar changes."( Metabolic mapping of MCF10A human breast cells via multiphoton fluorescence lifetime imaging of the coenzyme NADH.
Bird, DK; Eliceiri, KW; Keely, PJ; Ramanujam, N; Vaughan, EM; Vrotsos, KM; White, JG; Yan, L, 2005
)
1.05
"Pretreatment with potassium cyanide (KCN, a cytochrome pathway inhibitor) greatly increased CN-resistant R and reduced reactive oxygen species (ROS) formation, while application of salicylhydroxamic acid (SHAM, an AOX inhibitor) blocked the AOX activity and enhanced the production of ROS in the plants."( The reduction of reactive oxygen species formation by mitochondrial alternative respiration in tomato basal defense against TMV infection.
Dong, DK; Fu, LJ; Jiang, YP; Li, X; Liang, WS; Liao, YW; Shi, K; Xia, XJ; Yu, JQ; Zhang, S; Zhou, YH, 2012
)
0.7

Toxicity

Potassium cyanide abolishes the toxic effect of Abeta(25-35) to erythrocytes, whereas mercaptosuccinate, a glutathione peroxidase inhibitor, and ouabain, a Na+K+-ATPase inhibitors, promote it.

ExcerptReferenceRelevance
" We propose that oxidative events contribute to the toxic mechanism of action of methyl mercury in isolated cerebellar granule neurons."( Oxidative mechanisms underlying methyl mercury neurotoxicity.
Sarafian, T; Verity, MA, 1991
)
0.28
"To investigate the toxicity of potassium cyanide in fresh fruit and juice, male and female Wistar rats were orally dosed with fruit homogenates or juices containing 3 x LD50 of potassium cyanide."( Toxicity of potassium cyanide added to fresh fruit and juice.
Arnold, D; Bryce, F; Chadha, RK; Conacher, HB; Lawrence, JF, 1991
)
0.95
" Male C57BL/6N mice aged 2-3 (young), 10-12 (middle-aged), and 25-30 (old) months were administered KCN at 1, 2, 4, and 6 mg/kg po, and toxic manifestations were monitored for up to 2 hr."( Age-related changes in toxicity and biotransformation of potassium cyanide in male C57BL/6N mice.
Birnbaum, LS; McMahon, TF, 1990
)
0.52
" The approximate LD50 values calculated by this method showed little difference between two separate laboratories and were in good agreement with LD50 values reported in the literature."( A simple method for screening assessment of acute toxicity of chemicals.
Hashimoto, M; Kobayashi, K; Nishimura, M; Sekizawa, J; Tobe, M; Yamanaka, S, 1990
)
0.28
" The toxic effects were observed early during the development of the neuronal culture (from 4 days in vitro on) and seemed to be neuron-specific since astrocyte cultures were not affected."( Attenuation of neurotoxicity following anoxia or glutamate receptor activation in EGF- and hippocampal extract-treated neuronal cultures.
Leysen, JE; Pauwels, PJ; van Assouw, HP, 1989
)
0.28
"Pyridoxal 5'-phosphate (PLP), the active form of vitamin B6, readily forms complexes with a wide variety of potentially toxic substances, including cyanide (KCN), spermine (SPM), gentamicin (GM), and dopamine (DOP)."( Pyridoxal 5'-phosphate as an antidote for cyanide, spermine, gentamicin, and dopamine toxicity: an in vivo rat study.
Cabellon, S; Keniston, RC; Yarbrough, KS, 1987
)
0.27
" As target cell lysis is totally or partially inhibited by catalase, sodium azide and potassium cyanide, an involvement of toxic oxygen derivatives as cytolytic mediators was suggested."( Eosinophil-mediated cellular cytotoxicity induced by zymosan-activated serum.
De Simone, C; Ferrarelli, G; Ferrari, M; Pugnaloni, L; Rumi, C; Sorice, F, 1986
)
0.49
" Survival time was prolonged in rats treated with the toxic metals by pretreatment with NKK-105."( Effects of diiospropyl-1,3-dithiol-2-ylidene malonate (NKK-105) on acute toxicity of various drugs and heavy metals.
Hosokawa, T; Kitagawa, H; Saito, H; Sakamoto, K; Sugimoto, T; Yanaura, S, 1982
)
0.26
"A brief exposure of dissociated hippocampal culture to aluminum (AlCl3, 60 min) is toxic to neurons."( Aluminum toxicity in rat hippocampal neurons.
Brenner, SR; Yoon, KW, 1994
)
0.29
"Ischemia and hypoxia are major causes of renal failure and altered oxygen supply may affect renal responses to toxic chemicals."( Hypoxia and oxygen dependence of cytotoxicity in renal proximal tubular and distal tubular cells.
Lash, LH; Pedrosi, BM; Tokarz, JJ; Woods, EB, 1993
)
0.29
") increased LD50 values of CN(8."( Antidotal effect of dihydroxyacetone against cyanide toxicity in vivo.
Niknahad, H; O'Brien, PJ, 1996
)
0.29
" We report that, at high concentrations (300 microM-30 mM), a folic acid hexaglutamate analog is dose-dependently toxic to dissociated rat cortical cultures and that this toxicity is reversed by 2-PMPA, a potent and selective NAALADase inhibitor."( Toxicity induced by a polyglutamated folate analog is attenuated by NAALADase inhibition.
Olkowski, JL; Slusher, BS; Thomas, AG; Vornov, JJ, 1999
)
0.3
" It is primarily considered as a neurotoxin but its other toxic manifestations are also well documented."( Pharmacological interventions of cyanide-induced cytotoxicity and DNA damage in isolated rat thymocytes and their protective efficacy in vivo.
Bhattacharya, R; Lakshmana Rao, PV, 2001
)
0.31
"0 g kg(-1) and no toxic signs were observed in the surviving animals."( Acute toxicity studies of alpha-ketoglutarate: a promising antidote for cyanide poisoning.
Bhattacharya, R; Kumar, D; Pant, SC; Sugendran, K; Tulsawani, RK; Vijayaraghavan, R,
)
0.13
"Although exposure to cyanogenic plants or cyanide during pregnancy has adverse effects, no teratological study with cyanide has been conducted in goats or any other ruminant."( Prenatal toxicity of cyanide in goats--a model for teratological studies in ruminants.
Górniak, SL; Soto-Blanco, B, 2004
)
0.32
" It is an extremely toxic compound, so that problems and catastrophic accidents have recently occurred all around the globe."( Phytotoxicity of cyanide to weeping willow trees.
Trapp, S; Yu, X; Zhou, P, 2005
)
0.33
" Weeping willows grown in sandy soils survived the entire period (216 hours) without any toxic effect when irrigated with low doses of cyanide (3."( Phytotoxicity of cyanide to weeping willow trees.
Trapp, S; Yu, X; Zhou, P, 2005
)
0.33
"Chemicals taken up into plants may be accumulated so leading to toxic effects."( Uptake, metabolism, accumulation and toxicity of cyanide in Willow trees.
Larsen, M; Trapp, S; Ucisik, AS, 2005
)
0.33
"Fire combustion products contain a broad range of chemicals, which have a multitude of possible toxic interactions in humans."( In vitro cytotoxicity of selected chemicals commonly produced during fire combustion using human cell lines.
Green, AR; Hayes, AJ; Lestari, F; Markovic, B, 2005
)
0.33
"The LD50 of potassium cyanide (KCN) given orally (po), intraperitoneally (ip), subcutaneously (sc) or intravenously (iv) was determined in male mice, in the presence or absence alpha-KG given po, ip or iv."( Effect of pre-treatment of alpha-ketoglutarate on cyanide-induced toxicity and alterations in various physiological variables in rodents.
Bhattacharya, R; Kumar, D; Tulsawani, R, 2007
)
0.72
"75 LD50 KCN caused significant decrease in MAP and HR after 15 min, RR after 30 min and NMT after 60 min."( Effect of pre-treatment of alpha-ketoglutarate on cyanide-induced toxicity and alterations in various physiological variables in rodents.
Bhattacharya, R; Kumar, D; Tulsawani, R, 2007
)
0.34
" Potassium cyanide, a Cu,Zn-superoxide dismutase inhibitor, abolishes the toxic effect of Abeta(25-35) to erythrocytes, whereas mercaptosuccinate, a glutathione peroxidase inhibitor, and ouabain, a Na+,K+-ATPase inhibitor, promote it."( [Role of glycolysis and antioxidant enzymes in the toxicity of amyloid beta peptide Abeta25-35 to erythrocytes].
Kaminskiĭ, IuG; Kosenko, EA; Marov, NV; Pogosian, AS; Solomadin, IN; Venediktova, NI,
)
1.04
" Cyanide is predominantly a neurotoxin but its toxic manifestations in non-neuronal cells are also documented."( Oxidative stress mediated cytotoxicity of cyanide in LLC-MK2 cells and its attenuation by alpha-ketoglutarate and N-acetyl cysteine.
Bhattacharya, R; Hariharakrishnan, J; Prasad, GB; Satpute, RM, 2009
)
0.35
" The present work aimed to describe the toxic effects of cyanide, and to determine whether cyanide interferes with diet selection in quail (Coturnix coturnix)."( Cyanide toxicity and interference with diet selection in quail (Coturnix coturnix).
Cordeiro, LA; Rocha-e-Silva, RC; Soto-Blanco, B, 2010
)
0.36
" The concentration of the oxygen and resulting oxygen radicals produced by the zooxanthellae during photosynthesis are highly toxic to bacteria, which also assist corals in resisting the infection."( Neutralization of radical toxicity by temperature-dependent modulation of extracellular SOD activity in coral bleaching pathogen Vibrio shiloi and its role as a virulence factor.
Devaraj, SN; Murali, MR; Raja, SB, 2010
)
0.36
" We concluded that lyophilised aqueous extracts of Telfairia occidentalis showed good potential as a safe antidote for cyanide poisoning when administered concomitantly or very shortly after ingestion of sub-lethal dose of cyanide."( Modulating effect of aqueous extract of Telfairia occidentalis on induced cyanide toxicity in rats.
Bolaji, OM; Olabode, OO, 2011
)
0.37
"Hydrogen sulfide is a highly toxic gas-second only to carbon monoxide as a cause of inhalational deaths."( Hydrogen Sulfide--Mechanisms of Toxicity and Development of an Antidote.
Ali, S; Ambasudhan, R; Boss, GR; Brenner, M; Chan, A; Glasheen, M; Haushalter, KJ; Jiang, J; Lam, WL; Lipton, SA; Mahon, SB; Parker, J; Patel, HH; Pilz, RB; Saha, A, 2016
)
0.43
" Dimethyl trisulfide (DMTS), a sulfur-based molecule, binds cyanide converting it to the less toxic by-product thiocyanate."( Intramuscular dimethyl trisulfide: efficacy in a large swine model of acute severe cyanide toxicity.
Bebarta, VS; Brenner, M; Hendry-Hofer, TB; Lippner, DS; Mahon, SB; Ng, PC; Rockwood, GA; Witeof, AE, 2019
)
0.51
" No adverse effects were observed at the injection site."( Intramuscular dimethyl trisulfide: efficacy in a large swine model of acute severe cyanide toxicity.
Bebarta, VS; Brenner, M; Hendry-Hofer, TB; Lippner, DS; Mahon, SB; Ng, PC; Rockwood, GA; Witeof, AE, 2019
)
0.51
" Vitamins pre-treatment ameliorated toxic signs."( Modulatory Role of Vitamins A and E on Memory and Motor Functions of Cyanide Induced Neurotoxicity in Adult Swiss Mice.
Ishaku, AA; Mabrouk, M; Mohammed, A; Tanko, Y; Umar, AH, 2018
)
0.48
" Survival and other parameters, such as the time to recovery and assessment of clinical toxic signs (e."( A novel aqueous dimethyl trisulfide formulation is effective at low doses against cyanide toxicity in non-anesthetized mice and rats.
Dixon, H; Hildenberger, DM; Lippner, DS; McDonough, J; Rhoomes, MO; Rockwood, GA; Winborn, JN, 2022
)
0.72

Bioavailability

ExcerptReferenceRelevance
" In vitro radioiron uptake by isolated cells occurs by passive diffusion, is not regulated by the animal's iron status, and is primarily a function of bioavailability of iron in the incubating medium."( Iron transport by isolated rat intestinal mucosal cells.
Cook, JD; Savin, MA, 1978
)
0.26
" Acute toxicity of the formulation and bioavailability of α-KG were assessed in rats at the beginning of the experiment."( Accelerated stability and bioassay of a new oral α-ketoglutarate formulation for treating cyanide poisoning.
Bhattacharya, R; Gopalan, N; Rao, P; Shrivastava, S; Singh, AK; Singh, P; Yadav, SK, 2014
)
0.4

Dosage Studied

ExcerptRelevanceReference
" This effect was rapid (t1/2 less than 5 min) and had a similar dose-response relationship as the effect on glucose transport."( Insulin can rapidly increase cell surface insulin binding capacity in rat adipocytes. A novel mechanism related to insulin sensitivity.
Eriksson, J; Lönnroth, P; Smith, U, 1992
)
0.28
" Nitrite should not be given if the poisoning is mild or diagnosis is uncertain, to avoid excessive methemoglobin, dosage of sodium nitrite must be adjusted according to hemoglobin level (Table 1)."( Acute cyanide poisoning: a case report with toxicokinetic study.
Kaojarern, S; Wananukul, W, 1992
)
0.28
"To investigate the toxicity of potassium cyanide in fresh fruit and juice, male and female Wistar rats were orally dosed with fruit homogenates or juices containing 3 x LD50 of potassium cyanide."( Toxicity of potassium cyanide added to fresh fruit and juice.
Arnold, D; Bryce, F; Chadha, RK; Conacher, HB; Lawrence, JF, 1991
)
0.95
" Dizocilpine was active in this model at a dosage of 1 mg/kg."( Neuroprotective effect of memantine demonstrated in vivo and in vitro.
Krieglstein, J; Mennel, HD; Peruche, B; Rossberg, C; Seif el Nasr, M, 1990
)
0.28
" Afterwards, sodium thiosulphate was given additionally for 24 h at a dosage of 1 g per hour."( [Cyanide poisoning: treatment with hyperoxygenation and sodium thiosulphate].
Bock, TA; Heintz, B; Kierdorf, H; Sieberth, HG, 1990
)
0.28
" Dose-response studies revealed KCN, at doses of 10-15 mg/kg, produced significant elevations of whole-brain calcium 30 min after administration."( Cyanide-induced neurotoxicity: role of neuronal calcium.
Isom, GE; Johnson, JD; Meisenheimer, TL, 1986
)
0.27
" Maximum blood cyanide concentrations were observed 1 hr after dosing in mice but at 3 hr in rats."( Acrylonitrile: in vivo metabolism in rats and mice.
Ahmed, AE; Patel, K,
)
0.13
" This conclusion was based on the kinetics and dose-response relationships for the effects of azide and cyanide on H2O2 release and on the activities of catalase and myeloperoxidase."( Hydrogen peroxide metabolism in human monocytes during differentiation in vitro.
Cohn, ZA; Nakagawara, A; Nathan, CF, 1981
)
0.26
" Cytochrome redox responses were not altered either in magnitude or kinetics by hyperoxia; however, the cyanide-cytochrome dose-response curve was greatly shifted to the right by pretreatment with sodium nitrite, and the recovery rate of cytochrome a,a3 from cyanide-induced reduction was enhanced fourfold by pretreatment with sodium thiosulfate."( Cyanide-induced cytochrome a,a3 oxidation-reduction responses in rat brain in vivo.
Jöbsis, FF; Piantadosi, CA; Sylvia, AL, 1983
)
0.27
" DX lessened the reduction in adenosine triphosphate (ATP) and increased lactate contents in mice dosed with KCN and also lessened the reduction in ATP in the TCA cycle and oxidative phosphorylation reactions caused by KCN (0."( Dextrorphan attenuates the behavioral consequences of ischemia and the biochemical consequences of anoxia: possible role of N-methyl-d-aspartate receptor antagonism and ATP replenishing action in its cerebroprotecting profile.
Akaike, N; Himori, N; Imai, M; Kurasawa, M; Matsukura, T; Mishima, K; Tanaka, Y; Ueno, K; Watanabe, H, 1993
)
0.29
" Chemicals reported to be ciliotoxic in other systems were tested on hamster infundibula at various concentrations to determine whether a dose-response inhibition of ciliary beat frequency occurred."( Identification of cigarette smoke components that alter functioning of hamster (Mesocricetus auratus) oviducts in vitro.
DiCarlantonio, G; Gomez, C; Knoll, M; Talbot, P, 1998
)
0.3
"The dose-response relationships for DNA fragmentation (assessed by pulsed-field gel electrophoresis, PFGE) and for viability (evaluated by measuring the reduction of MTT dye which can be accomplished by viable cells only) were investigated in order to discriminate between genotoxicity and cytotoxicity in the pathogenesis of DNA double-strand breaks (DSB)."( Discrimination between genotoxicity and cytotoxicity in the induction of DNA double-strand breaks in cells treated with etoposide, melphalan, cisplatin, potassium cyanide, Triton X-100, and gamma-irradiation.
Hoffmann, HD; Hormes, P; Lutz, WK; Vamvakas, S; Vock, EH, 1998
)
0.5
" Thirty-four male goats were divided into five groups dosed with KCN at 0 (control)."( Physiopathological effects of the administration of chronic cyanide to growing goats--a model for ingestion of cyanogenic plants.
Górniak, SL; Kimura, ET; Soto-Blanco, B, 2001
)
0.31
" When cyanide poisoning was suspected he received antidote therapy, administered initially with interval dosing and then as a continuous infusion."( Acute cyanide poisoning.
Peddy, SB; Rigby, MR; Shaffner, DH, 2006
)
0.33
" To reach this goal we performed a dose-response curve to microinjection of increasing dose of noradrenaline into the caudal commissural NTS of awake rats and then the threshold dose, which produces minor changes in the baseline mean arterial pressure, was selected to be used in the chemoreflex experiment."( Noradrenergic inhibitory modulation in the caudal commissural NTS of the pressor response to chemoreflex activation in awake rats.
Bonagamba, LG; Machado, BH; Silva de Oliveira, LC, 2007
)
0.34
" Analysis of the data showed that the incomplete revision of NGF should be not due to the dosage of NGF we used."( Nerve growth factor protects the cortical neurons from chemical hypoxia-induced injury.
Du, F; Qian, ZM; Wu, XM; Yang, L; Zhu, L, 2008
)
0.35
" Histological changes were found only in animals dosed with cyanide, and these consisted of mild hepatic periportal vacuolation, an increased number of vacuoles in the colloid of the thyroid glands, and spongiosis in the mesencephalon."( Cyanide toxicity and interference with diet selection in quail (Coturnix coturnix).
Cordeiro, LA; Rocha-e-Silva, RC; Soto-Blanco, B, 2010
)
0.36
" Rabbits in the experimental group were orally dosed with KCN at 3mg/kg body weight for 40 consecutive days."( Prolonged oral cyanide effects on feed intake, growth rate and blood parameters in rabbits.
Ashraf, K; Avais, M; Hameed, S; Khan, JA; Khan, MA; Khan, MS, 2014
)
0.4
" This study describes the short- and long-term sensory, motor, cognitive, and behavioral changes associated with oral dosing of a sublethal but toxic dose of KCN utilizing functional observation battery and Tier II CNS testing in adult and juvenile mice of both sexes."( Neurobehavioral and Cardiovascular Effects of Potassium Cyanide Administered Orally to Mice.
Hawk, MA; Henderson, KA; Knostman, KA; Ma, ZJ; Matthews, CM; Ritchie, GD; Roche, BM; Sabourin, CL; Sabourin, PJ; Wakayama, EJ, 2016
)
0.69
" Further, we calculated both the mass balance of thiocyanate and the resultant plausible dosage of cyanide from the data reported in the previously published method."( Can excreted thiocyanate be used to detect cyanide exposure in live reef fish?
Andrade, L; Breen, NE; Loewenstein, J; Metivier, R; Rhyne, AL, 2018
)
0.48
"Findings will provide timely information on the safety, efficacy, and optimal dosing of t-PA to treat moderate/severe COVID-19-induced ARDS, which can be rapidly adapted to a phase III trial (NCT04357730; FDA IND 149634)."(
Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y, 2022
)
0.72
" Dose-response testing was performed on a subset of assays that showed interferences ≥10%."( Hydroxocobalamin interference in routine laboratory tests: Development of a protocol for identifying samples and reporting results from patients treated with Cyanokit
Babiak, C; Dang, S; Füzéry, AK; Herndon, R; Raizman, JE; Szkotak, A; Tsui, AK, 2021
)
0.62
" Dose-response studies showed dose-dependent increases and/or decreases consistent with initial spiking studies."( Hydroxocobalamin interference in routine laboratory tests: Development of a protocol for identifying samples and reporting results from patients treated with Cyanokit
Babiak, C; Dang, S; Füzéry, AK; Herndon, R; Raizman, JE; Szkotak, A; Tsui, AK, 2021
)
0.62
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
EC 1.9.3.1 (cytochrome c oxidase) inhibitorAn EC 1.9.3.* (oxidoreductase acting on donor heme group, oxygen as acceptor) inhibitor that interferes with the action of cytochrome c oxidase (EC 1.9.3.1).
EC 1.15.1.1 (superoxide dismutase) inhibitornull
neurotoxinA poison that interferes with the functions of the nervous system.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
cyanide salt
one-carbon compoundAn organic molecular entity containing a single carbon atom (C1).
potassium saltAny alkali metal salt having potassium(1+) as the cation.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (43)

PathwayProteinsCompounds
N-methyl-u03941-pyrrolinium cation biosynthesis021
u03B2-pyrazole-1-ylalanine biosynthesis012
gossypetin metabolism025
willardiine and isowillardiine biosynthesis010
eupatolitin 3-O-glucoside biosynthesis030
guanosine nucleotides degradation II125
superpathway of hyoscyamine and scopolamine biosynthesis434
adenosine nucleotides degradation I327
leucopelargonidin and leucocyanidin biosynthesis516
superpathway of purines degradation in plants745
sanguinarine and macarpine biosynthesis639
superpathway of guanosine nucleotides degradation (plants)227
guanosine nucleotides degradation I226
purine nucleotides degradation I (plants)334
secologanin and strictosidine biosynthesis1336
nitrate reduction III (dissimilatory)1219
nitrate reduction VIII (dissimilatory)1915
nitrate reduction IX (dissimilatory)920
superpathway of glycol metabolism and degradation1035
leucopelargonidin and leucocyanidin biosynthesis720
sanguinarine and macarpine biosynthesis839
succinate to cytochrome bo oxidase electron transfer831
1,4-dichlorobenzene degradation919
NADH to cytochrome bd oxidase electron transfer II418
NADH to cytochrome bo oxidase electron transfer II526
D-lactate to cytochrome bo oxidase electron transfer527
glycerol-3-phosphate to cytochrome bo oxidase electron transfer529
proline to cytochrome bo oxidase electron transfer531
succinate to cytochrome bd oxidase electron transfer723
NADH to cytochrome bo oxidase electron transfer I1734
NADH to cytochrome bd oxidase electron transfer I1627
pyruvate to cytochrome bo oxidase electron transfer535
D-galactarate degradation I530
superpathway of L-lysine degradation33112
L-lysine degradation V133
superpathway of microbial D-galacturonate and D-glucuronate degradation3592
adenosine nucleotides degradation I227
purine nucleotides degradation I (plants)234
N-methyl-u03941-pyrrolinium cation biosynthesis027
nitrilotriacetate degradation222
L-tryptophan degradation VI (via tryptamine)319
taurine biosynthesis II219
taurine biosynthesis I420
glycolate and glyoxylate degradation I726
glycolate and glyoxylate degradation II415
nitroethane degradation115
superpathway of hyoscyamine and scopolamine biosynthesis441
superpathway of D-glucarate and D-galactarate degradation637
willardiine and isowillardiine biosynthesis011
u03B2-pyrazole-1-ylalanine biosynthesis013
superpathway of purines degradation in plants645
trans-4-hydroxy-L-proline degradation II643
eupatolitin 3-O-glucoside biosynthesis031

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Polyphenol oxidase 2Agaricus bisporusIC50 (µMol)24.00000.03403.987110.0000AID1082239
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (10)

Assay IDTitleYearJournalArticle
AID1683660Inhibition of mitochondrial membrane potential in Trypanosoma cruzi MHOM/Pe/2011/Arequipa(DTU V) epimastigote form at IC25 concentration after 72 hrs by Rho (FITC-A) staining based flow cytometric analysis2020Journal of natural products, 12-24, Volume: 83, Issue:12
In Vivo Biological Evaluation of a Synthetic Royleanone Derivative as a Promising Fast-Acting Trypanocidal Agent by Inducing Mitochondrial-Dependent Necrosis.
AID1082232Inhibition of xanthine oxidase at IC50 concentration2011Journal of agricultural and food chemistry, May-11, Volume: 59, Issue:9
Neonicotinoid insecticides: oxidative stress in planta and metallo-oxidase inhibition.
AID1104255Inhibition of respiratory activity in Botryotinia fuckeliana mycelium assessed as decrease in rate of oxygen consumption at 1 mM by Clark-type oxygen electrode recording analysis in presence of succinate and 2 mM mitochondrial alternative oxidase inhibito2009Pest management science, Dec, Volume: 65, Issue:12
Inhibitory effect of bionic fungicide 2-allylphenol on Botrytis cinerea (Pers. ex Fr.) in vitro.
AID1104266Inhibition of respiratory activity in Botryotinia fuckeliana mycelium assessed as decrease in rate of oxygen consumption at 1 mM by Clark-type oxygen electrode recording analysis in presence of glucose (Rvb = 0%)2009Pest management science, Dec, Volume: 65, Issue:12
Inhibitory effect of bionic fungicide 2-allylphenol on Botrytis cinerea (Pers. ex Fr.) in vitro.
AID1082237Inhibition of xanthine oxidase2011Journal of agricultural and food chemistry, May-11, Volume: 59, Issue:9
Neonicotinoid insecticides: oxidative stress in planta and metallo-oxidase inhibition.
AID1265721Toxicity in iv dosed mouse measured for 24 hrs2015Journal of medicinal chemistry, Dec-10, Volume: 58, Issue:23
Cyanohydrin as an Anchoring Group for Potent and Selective Inhibitors of Enterovirus 71 3C Protease.
AID1082238Inhibition of Oryctolagus cuniculus (rabbit) AOX in liver cytosol2011Journal of agricultural and food chemistry, May-11, Volume: 59, Issue:9
Neonicotinoid insecticides: oxidative stress in planta and metallo-oxidase inhibition.
AID1104265Inhibition of respiratory activity in Botryotinia fuckeliana mycelium assessed as decrease in rate of oxygen consumption at 1 mM by Clark-type oxygen electrode recording analysis in presence of succinate (Rvb = 0%)2009Pest management science, Dec, Volume: 65, Issue:12
Inhibitory effect of bionic fungicide 2-allylphenol on Botrytis cinerea (Pers. ex Fr.) in vitro.
AID1082239Inhibition of Agaricus bisporus (mushroom) tyrosinase2011Journal of agricultural and food chemistry, May-11, Volume: 59, Issue:9
Neonicotinoid insecticides: oxidative stress in planta and metallo-oxidase inhibition.
AID1104256Inhibition of respiratory activity in Botryotinia fuckeliana mycelium assessed as decrease in rate of oxygen consumption at 1 mM by Clark-type oxygen electrode recording analysis in presence of glucose and 2 mM mitochondrial alternative oxidase inhibitor,2009Pest management science, Dec, Volume: 65, Issue:12
Inhibitory effect of bionic fungicide 2-allylphenol on Botrytis cinerea (Pers. ex Fr.) in vitro.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (1,677)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990688 (41.03)18.7374
1990's475 (28.32)18.2507
2000's335 (19.98)29.6817
2010's167 (9.96)24.3611
2020's12 (0.72)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 78.39

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index78.39 (24.57)
Research Supply Index7.47 (2.92)
Research Growth Index4.24 (4.65)
Search Engine Demand Index143.25 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (78.39)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (0.17%)5.53%
Reviews14 (0.80%)6.00%
Case Studies49 (2.79%)4.05%
Observational1 (0.06%)0.25%
Other1,690 (96.19%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]